0001209191-14-051234.txt : 20140807
0001209191-14-051234.hdr.sgml : 20140807
20140807180254
ACCESSION NUMBER: 0001209191-14-051234
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140805
FILED AS OF DATE: 20140807
DATE AS OF CHANGE: 20140807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001365216
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133929237
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 3019613400
MAIL ADDRESS:
STREET 1: 4520 EAST-WEST HIGHWAY, 3RD FLOOR
CITY: BETHESDA
STATE: MD
ZIP: 20814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ueno Ryuji
CENTRAL INDEX KEY: 0001384370
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33609
FILM NUMBER: 141025108
MAIL ADDRESS:
STREET 1: 4520 EAST-WEST HIGHWAY
STREET 2: SUITE 300
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-08-05
0
0001365216
Sucampo Pharmaceuticals, Inc.
SCMP
0001384370
Ueno Ryuji
4520 EAST-WEST HIGHWAY
SUITE 300
BETHESDA
MD
20814
0
0
1
0
Class A Common Stock
2014-08-05
4
S
0
84243
6.2408
D
22558286
I
By S&R Technology Holdings, LLC
Class A Common Stock
2014-08-06
4
S
0
30523
6.3231
D
22527763
I
By S&R Technology Holdings, LLC
Class A Common Stock
2014-08-07
4
S
0
66961
6.3148
D
22460802
I
By S&R Technology Holdings, LLC
Class A Common Stock
353530
D
Class A Common Stock
60357
I
By Wife
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by S&R Technology Holdings, LLC on September 11, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.13 to $6.37, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.02 to $6.41, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.46, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Dr. Ueno disclaims beneficial ownership of the reported securities.
/s/ Kei Tolliver, by Power of Attorney
2014-08-07